4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000899243-18-030649
Chief Executive Officer acquired 21,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Kulkarni Samarth · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-12-07 | Exercise or conversion : show line 1 in the form | +21,500 | $1.81 | $38,915 | 167,290 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-12-07 | Exercise or conversion : show line 2 in the form Stock Options (Right to Buy) | −21,500 | 243,058 | D |
Loading xslF345X03/doc4.xml…